| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |